Related Experiment Video
Updated: Apr 7, 2026

08:27
Large-Scale Multi-Omics Genome-Wide Association Studies Mo-GWAS: Guidelines for Sample Preparation and Normalization
Published on: July 27, 2021
5.0K
Phenome-Wide Association Studies: Leveraging Comprehensive Phenotypic and Genotypic Data for Discovery
Current Genetic Medicine Reports
|July 7, 2015
Summary
Phenome-Wide Association Studies (PheWAS) explore connections between genes and health traits using large datasets. This approach identifies novel genotype-phenotype links, advancing our understanding of complex diseases and genetic biomarkers.
Area of Science:
- Genetics and Genomics
- Computational Biology
- Epidemiology
Background:
- Increasingly large volumes of clinical, epidemiological, and genotypic data are available.
- High-performance computing resources enable comprehensive analysis of phenome-genome connections.
- Phenome-Wide Association Studies (PheWAS) offer a powerful approach to explore these complex relationships.
Purpose of the Study:
- To review the application and methodologies of Phenome-Wide Association Studies (PheWAS).
- To highlight PheWAS as a tool for identifying novel genotype-phenotype associations and generating research hypotheses.
- To discuss the potential of PheWAS in uncovering mechanistic insights and elucidating the genetic architecture of complex traits.
Main Methods:
- Evaluating the association between genetic variants or clinical variables and a wide range of phenotypes.
- Utilizing data from epidemiological studies, clinical trials, and electronic health records.
- Reviewing analytical methodologies and emerging methods for evaluating PheWAS results, including genotype-phenotype networks.
Main Results:
- PheWAS facilitates the identification of novel connections between multiple phenotypes and the broader phenotype-genotype landscape.
- This approach aids in generating new hypotheses and narrowing research search spaces.
- PheWAS is instrumental in discovering new biomarkers, understanding complex trait genetics, and uncovering pleiotropy.
Conclusions:
- PheWAS represents a significant advancement over traditional Genome-Wide Association Studies (GWAS) by examining numerous phenotypes simultaneously.
- The PheWAS approach provides valuable mechanistic insights and aids in biomarker discovery.
- Future developments in PheWAS methodologies promise further advancements in understanding genotype-phenotype relationships.
Keywords:
Electronic Health Record (EHR)International Classification of Disease Codes (ICD)genotype-phenotype networksphenomicspleiotropyMore Related Videos
Related Concept Videos
Genome-wide Association Studies-GWAS
16.7K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
16.7K
Genomics
41.8K
Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
41.8K
Pharmacogenomics: Identification of New Drug Targets
88
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
88
Polygenic Traits
70.6K
When more than one gene is responsible for a given phenotype, the trait is considered polygenic. Human height is a polygenic trait. Studies have uncovered hundreds of loci that influence height, and there are believed to be many more. Due to the high number of genes involved, as well as environmental and nutritional factors, height varies significantly within a given population. The distribution of height forms a bell-shaped curve, with relatively few individuals in the population at the...
70.6K
Polygenic Traits
11.5K
11.5K
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
119
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
119

